Quantcast

Latest PDE5 inhibitor Stories

2014-07-23 08:32:10

SEOUL, South Korea, July 23, 2014 /PRNewswire/ -- Mezzion Pharma Co. Ltd., announced that it has initiated a clinical program to evaluate the use of udenafil to treat adolescents who have undergone the Fontan surgical palliation for single ventricle heart defects. The clinical program will follow protocols developed by a subcommittee made up of representatives of the Pediatric Heart Network (PHN), a multi-center clinical research network funded by the National Heart, Lung, and Blood...

2014-01-10 08:24:18

SEOUL, Korea, Jan. 10, 2014 /PRNewswire/ -- Mezzion Pharma Co. Ltd., announced that it has signed an agreement with New England Research Institutes, Inc., who are authorized by the National Heart, Lung, and Blood Institute-supported Pediatric Heart Network (PHN) to manage and conduct clinical trials on its behalf. The clinical studies to be conducted under this agreement were developed by a subcommittee made up of representatives of the PHN. The studies will be funded by a grant...

2011-06-17 05:45:00

MOUNTAIN VIEW, Calif., June 17, 2011 /PRNewswire/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that the positive results from REVIVE-RP (TA-303), a phase 3 clinical trial evaluating the safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction (ED),will be presented this afternoon at the 2011 Cancer Survivorship and Sexual Health Symposium in Washington D.C. The meeting is jointly sponsored by the International Society for Sexual Medicine (ISSM)...

2011-06-14 05:45:00

MOUNTAIN VIEW, Calif., June 14, 2011 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today announced that VIVUS management will participate in two investment conferences during the month of June. The conference presentation schedule is as follows: Bank of America Merrill Lynch Specialty Pharmaceuticals One-on- One Conference June 16, 2011 Presenter: Dr. Barbara Troupin, senior director, medical affairs Boston Harbor Hotel, Boston, MA 2011 Wells Fargo Securities...

2011-02-25 05:45:00

MOUNTAIN VIEW, Calif., Feb. 25, 2011 /PRNewswire/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that Timothy Morris, chief financial officer, will present an overview of the company at three investment conferences during the month of March. The conference presentation schedule is as follows: Citi's 2011 Global Health Care Conference March 1, 2011 at 4:00 p.m. ET Hilton New York Hotel, New York,...

2010-12-03 06:00:00

MOUNTAIN VIEW, Calif., Dec. 3, 2010 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that senior management will present an overview of the company at two investment conferences during the month of December. The conference presentation schedule is as follows: Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference December 8, 2010 at 12:30 p.m. PT Nikko Hotel, San Francisco, CA Presenter: Charles Bowden, MD, director of...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.